Taking Stock of COVID-19

Amorim dos Santos J Normando AGC Carvalho da Silva RL Acevedo AC De Luca Canto G Sugaya N Santos-Silva AR Guerra ENS . 2021. Oral manifestations in patients with COVID-19: a living systematic review. J Dent Res. 100(2):141–154.

Azzi L Maurino V Baj A Dani M d’Aiuto A Fasano M Lualdi M Sessa F Alberio T . 2021. Diagnostic salivary tests for SARS-CoV-2. J Dent Res. 100(2):115–123.

Bescos R Casas-Agustench P Belfield L Brookes Z Gabaldón T . 2020. Coronavirus disease 2019 (COVID-19): emerging and future challenges for dental and oral medicine. J Dent Res. 99(9):1113.

Carrouel F Gonçalves LS Conte MP Campus G Fisher J Fraticelli L Gadea-Deschamps E Ottolenghi L Bourgeois D . 2021. Antiviral activity of reagents in mouth rinses against SARS-CoV-2. J Dent Res. 100(2):124–132.

Chen Q Allot A Lu Z . 2020. LitCovid: an open database of COVID-19 literature. Nucleic Acids Res. gkaa952.

Eberhard J Jepsen S Jervøe-Storm PM Needleman I Worthington HV . 2015. Full-mouth treatment modalities (within 24 hours) for chronic periodontitis in adults. Cochrane Database Syst Rev. (4):CD004622.

Gupta S Mohindra R Chauhan PK Singla V Goyal K Sahni V Gaur R Verma DK Ghosh A Soni RK , et al. 2021. SARS-CoV-2 detection in gingival crevicular fluid. J Dent Res. 100(2):187–193.

Huang N Perez P Kato T Mikami Y Okuda K Gilmore RC Domínguez Conde C Gasmi B Stein S Beach M , et al. 2020. Integrated single-cell atlases reveal an oral SARS-CoV-2 infection and transmission axis. medRxiv [epub ahead of print 27 Oct 2020]. doi:10.1101/2020.10.26.20219089

Marui VC Souto MLS Rovai ES Romito GA Chambrone L Pannuti CM . 2019. Efficacy of preprocedural mouthrinses in the reduction of microorganisms in aerosol: a systematic review. J Am Dent Assoc. 150(12):1015–1026.e1011.

US Food and Drug Administration. 2020. Coronavirus (COVID-19) update: FDA issues emergency use authorization to Yale school of public health for salivadirect, which uses a new method of saliva sample processing [accessed 2020 Nov]. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-emergency-use-authorization-yale-school-public-health.

van Dorp L Acman M Richard D Shaw LP Ford CE Ormond L Owen CJ Pang J Tan CCS Boshier FAT , et al. 2020. Emergence of genomic diversity and recurrent mutations in SARS-CoV-2. Infect Genet Evol. 83:104351.

Zheng J . 2020. SARS-CoV-2: an emerging coronavirus that causes a global threat. Int J Biol Sci. 16(10):1678–1685.